Cargando…
The journey of remdesivir: from Ebola to COVID-19
Countries around the world are currently fighting the coronavirus disease 2019 (COVID-19) pandemic, which is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). SARS-CoV-2 is a betacoronavirus, belonging to the same genus as severe acute respiratory syndrome (SARS)-CoV and Middle...
Autores principales: | Pardo, Joe, Shukla, Ashutosh M, Chamarthi, Gajapathiraju, Gupte, Asmita |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioExcel Publishing Ltd
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7250494/ https://www.ncbi.nlm.nih.gov/pubmed/32547625 http://dx.doi.org/10.7573/dic.2020-4-14 |
Ejemplares similares
-
Remdesivir: From Ebola to COVID-19
por: Santoro, M. Gabriella, et al.
Publicado: (2021) -
Why Remdesivir Failed: Preclinical Assumptions Overestimate the Clinical Efficacy of Remdesivir for COVID-19 and Ebola
por: Yan, Victoria C., et al.
Publicado: (2021) -
Penile lesion in a dialysis patient: Time to get an X‐ray
por: Koratala, Abhilash, et al.
Publicado: (2018) -
Wunderlich syndrome
por: Chamarthi, Gajapathiraju, et al.
Publicado: (2018) -
Remdesivir : d’Ebola à la Covid ?
por: Dalmat, Yann-Mickael
Publicado: (2021)